Skip Nav Destination
Issues
Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study.
Diabetes Care June 2000, Vol.23, 726-732. doi:https://doi.org/10.2337/diacare.23.6.726
Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes.
Diabetes Care June 2000, Vol.23, 733-738. doi:https://doi.org/10.2337/diacare.23.6.733
The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy.
Diabetes Care June 2000, Vol.23, 739-743. doi:https://doi.org/10.2337/diacare.23.6.739
Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group.
S E Geerlings; R P Stolk; M J Camps; P M Netten; J B Hoekstra; K P Bouter; B Bravenboer; J T Collet; A R Jansz; A I Hoepelman
Diabetes Care June 2000, Vol.23, 744-749. doi:https://doi.org/10.2337/diacare.23.6.744
Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes.
Diabetes Care June 2000, Vol.23, 750-753. doi:https://doi.org/10.2337/diacare.23.6.750
Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study.
Diabetes Care June 2000, Vol.23, 759-764. doi:https://doi.org/10.2337/diacare.23.6.759
Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation.
Diabetes Care June 2000, Vol.23, 765-769. doi:https://doi.org/10.2337/diacare.23.6.765
Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study.
Diabetes Care June 2000, Vol.23, 770-774. doi:https://doi.org/10.2337/diacare.23.6.770
Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
Diabetes Care June 2000, Vol.23, 775-778. doi:https://doi.org/10.2337/diacare.23.6.775
Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.
Diabetes Care June 2000, Vol.23, 779-785. doi:https://doi.org/10.2337/diacare.23.6.779
Association of HELLP syndrome with autoimmune antibodies and glucose intolerance.
Diabetes Care June 2000, Vol.23, 786-790. doi:https://doi.org/10.2337/diacare.23.6.786
MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Diabetes Care June 2000, Vol.23, 791-795. doi:https://doi.org/10.2337/diacare.23.6.791
Long-term follow-up in diabetic Charcot feet with spontaneous onset.
Diabetes Care June 2000, Vol.23, 796-800. doi:https://doi.org/10.2337/diacare.23.6.796
Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women.
Diabetes Care June 2000, Vol.23, 801-806. doi:https://doi.org/10.2337/diacare.23.6.801
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Diabetes Care June 2000, Vol.23, 807-812. doi:https://doi.org/10.2337/diacare.23.6.807
Diabetes in urban African-Americans. XIX. Prediction of the need for pharmacological therapy.
Diabetes Care June 2000, Vol.23, 820-825. doi:https://doi.org/10.2337/diacare.23.6.820
Is there a glycemic threshold for impaired autonomic control?
Diabetes Care June 2000, Vol.23, 826-830. doi:https://doi.org/10.2337/diacare.23.6.826
High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
K Decochez; J Tits; J L Coolens; L Van Gaal; G Krzentowski; F Winnock; E Anckaert; I Weets; D G Pipeleers; F K Gorus
Diabetes Care June 2000, Vol.23, 838-844. doi:https://doi.org/10.2337/diacare.23.6.838
Healthy people 2010: diabetes.
Diabetes Care June 2000, Vol.23, 853-855. doi:https://doi.org/10.2337/diacare.23.6.853
Role of triglyceride levels in identifying insulin resistance in nonobese type 2 diabetic Japanese patients with hypertension.
A Taniguchi; M Fukushima; M Sakai; I Nagata; S Nagasaka; K Doi; H Kinoshita; N Kanda; K Tokuyama; Y Nakai
Diabetes Care June 2000, Vol.23, 856-857. doi:https://doi.org/10.2337/diacare.23.6.856
Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: role of serum triglyceride levels.
A Taniguchi; M Fukushima; M Sakai; S Nagasaka; K Doi; I Nagata; K Matsushita; Y Ooyama; A Kawamoto; M Nakasone; K Tokuyama; Y Nakai
Diabetes Care June 2000, Vol.23, 857-858. doi:https://doi.org/10.2337/diacare.23.6.857
Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease.
Diabetes Care June 2000, Vol.23, 859-860. doi:https://doi.org/10.2337/diacare.23.6.859
Breath hydrogen testing identifies patients with diabetic gastroparesis.
Diabetes Care June 2000, Vol.23, 860-861. doi:https://doi.org/10.2337/diacare.23.6.860
Insulin-induced hypoglycemia induces a rise in C-reactive protein.
Diabetes Care June 2000, Vol.23, 861-862. doi:https://doi.org/10.2337/diacare.23.6.861
Trp64Arg polymorphism of the beta3-adrenergic receptor is not associated with diabetic nephropathy in Japanese patients with type 2 diabetes.
Diabetes Care June 2000, Vol.23, 862-863. doi:https://doi.org/10.2337/diacare.23.6.862
Cautionary note regarding HbA1c methods predicting the clinical status of diabetic patients.
Diabetes Care June 2000, Vol.23, 867-869. doi:https://doi.org/10.2337/diacare.23.6.867
Hemophilus vaccine associated with increased risk of diabetes: causality likely.
Diabetes Care June 2000, Vol.23, 872-873. doi:https://doi.org/10.2337/diacare.23.6.872
HbA1c determination with high-performance liquid chromatography.
Diabetes Care June 2000, Vol.23, 874-875. doi:https://doi.org/10.2337/diacare.23.6.874a
Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
Diabetes Care June 2000, Vol.23, 874. doi:https://doi.org/10.2337/diacare.23.6.874b
The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability.
Diabetes Care June 2000, Vol.23, 875. doi:https://doi.org/10.2337/diacare.23.6.875
